Lectureship endowment funds are created to honor major contributions that have clearly advanced a field. Such was the case in the creation of the Wulf H. Utian Endowed Lectureship Fund. In some select cases, they recognize the contributions of a transformational leader. The express purpose of the fund is to provide travel to the Annual Meeting by a lecturer selected by The North American Menopause Society Scientific Program Committee. Wulf H. Utian changed the paradigm for menopause by creating an organization whose major purpose was to use an integrated approach to the condition. Such an approach would benefit many areas of health care. This report summarizes my thoughts on how such an integrated approach might advance the field of primary ovarian insufficiency.
From the Integrative Reproductive Medicine Group, Intramural Research Program on Reproductive and Adult Endocrinology, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Clinical Research Center, Bethesda, MD.
Received January 20, 2011; revised and accepted February 3, 2011.
Funding/support: The content of this article was presented by Dr. Nelson during The North American Menopause Society (NAMS)/Pfizer Wulf H. Utian Endowed Lecture on October 8, 2010, in Chicago, IL. An endowment to NAMS from Pfizer established this annual lectureship, with faculty selected by the NAMS Scientific Program Committee.
Financial disclosure/conflicts of interest: None reported.
Address correspondence to: Lawrence M. Nelson, MD, CAPT USPHS, Integrative Reproductive Medicine Group, Intramural Research Program on Reproductive and Adult Endocrinology, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, CRC, Room 1-3140, 10 Center Drive, MSC-1109, Bethesda, MD 20892-1109. E-mail: Lawrence_Nelson@nih.gov